Skip to main content
. Author manuscript; available in PMC: 2022 Apr 21.
Published in final edited form as: J Gastrointest Surg. 2019 Jul 16;24(8):1729–1735. doi: 10.1007/s11605-019-04320-y

Table 3:

Operative and Postoperative Outcomes

n=124

Completed minimally invasive 119 (96.0)
Side-to-side 6-cm anastomosis 118 (95.2)
EBL (mL, n=109) 150 [100,200]
Operative time (min, n=102) 463 [403,515]
Pyloric botulinum injection 80/108 (74.1)
Any postoperative complication 64 (51.6)
 Delayed gastric emptying 23 (18.5)
 Respiratory
Failure requiring intubation 8 (6.5)
Failure not requiring intubation 6 (4.8)
Aspiration 14 (11.3)
Pneumonia 12 (9.7)
Pneumothorax 6 (4.8)
 Arrhythmia 15 (12.1)
 Anastomotic leak 9 (7.3)
 RLN paresis 3 (2.4)
 Pulmonary embolism 4 (3.2)
 Surgical site infection 3 (2.4)
 Chyle leak 2 (1.6)
 Deep vein thrombosis 2 (1.6)
Reoperation 7 (5.6)
Length of stay (days) 8 [7,11]
Disposition to home 94/114 (82.5)
30-day readmission 15 (12.1)
Mortality
30-day 1/123 (0.8)
90-day 3/122 (2.5)

Reported as number (percent) or median [IQR]. If data were not available for the entire cohort, reported as number/total (percent).

EBL, estimated blood loss; RLN, recurrent laryngeal nerve.